Publication Date:
2013-03-21
Description:
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer British Journal of Cancer 108, 1100 (19 March 2013). doi:10.1038/bjc.2013.31 Authors: F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, C A Papadimitriou, C Dimitrakakis, A Tsigginou, I Papaspyrou, A Giannos, M-A Dimopoulos & M Filipits
Keywords:
biomarkersprognosisMETtriple-negative breast cancer
Print ISSN:
0007-0920
Electronic ISSN:
1532-1827
Topics:
Medicine
Permalink